Compounds > mesalamine

mesalamine and mercaptopurine

mesalamine has been researched along with mercaptopurine in 142 studies

Research

Studies (142)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's19 (13.38)18.2507
2000's47 (33.10)29.6817
2010's73 (51.41)24.3611
2020's3 (2.11)2.80

Authors

AuthorsStudies
Lipsky, JJ; Mahoney, DW; Mays, DC; Sandborn, WJ; Tremaine, WJ; Van Os, EC; Zins, BJ; Zinsmeister, AR1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Collins, MT; Shin, SJ1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Fischbach, W1
Goldstein, F1
Cohen, SA; Daum, F; Glassman, M; Holmes, RD; Markowitz, J; Piccoli, D; Rossi, TM; Treem, WR; Ulshen, MH; Winter, HS1
Goebell, H; Kölbel, C1
Szumlanski, CL; Weinshilboum, RM1
Stark, ME; Tremaine, WJ1
Ament, ME; Vargas, JH1
van Hogezand, RA1
Peppercom, MA1
Bodian, C; George, J; Pou, R; Present, DH; Rubin, PH1
Fleisher, M; Kim, P; Korelitz, BI; Sasson, M; Zlatanic, J1
Khatchatourian, M; Seaton, TL1
Arber, N; Becker, S; Broide, E; Eliakim, R; Fich, A; Gilat, T; Keter, D; Lavy, A; Moshkowitz, M; Odes, S; Oren, R; Patz, J; Pomeranz, I; Reisfeld, I; Shirin, C; Shirin, H; Villa, Y1
Rutgeerts, P1
Buffinton, GD; Doe, WF; McKenzie, SM1
Lowry, PW; Sandborn, WJ; Szumlanski, CL; Weinshilboum, RM1
Gleim, GW; Kim, PS; Korelitz, BI; Zlatanic, J1
Green, JR1
Dubinsky, MC; Lamothe, S; Seidman, EG; Sinnett, D; Targan, SR; Théorêt, Y; Yang, HY1
Present, DH1
Hart, MH; Saulsbury, FT1
Rutgeerts, PJ1
Decker, GA; Loftus, EV; Pasha, TM; Sandborn, WJ; Tremaine, WJ1
Alexander, JS; Grisham, MB; Itoh, M; Joh, T; Jordan, P; Manas, K; Oshima, T; Pavlick, K1
Franklin, CL; Lipsky, JJ; Loftus, EV; Lowry, PW; Mays, DC; Sandborn, WJ; Szumlanski, CL; Tremaine, WJ; Weaver, AL; Weinshilboum, RM1
Bitton, A1
Kamm, MA2
Schölmerich, J1
Fleig, WE1
Nagy, F1
France, R; Kinney, T; Kozarek, R; Patterson, D; Rawlins, M1
Kullak-Ublick, GA; Rammert, Ch1
Barlam, TF; McCloud, E1
Fölsch, UR; Kühbacher, T; Schreiber, S1
Cohen, RD; Hanauer, SB; Korelitz, BI; Peppercorn, MA; Present, DH; Rutgeerts, P; Thisted, RA1
Harris, AW; Hayee, BH1
Tomomasa, T1
Fleisher, D; Kesisoglou, F; Lee, JW; Niemiec, S; Zhou, SY; Zimmermann, EM1
Bierau, J; Bos, LP; Derijks, LJ; Engels, LG; Gilissen, LP; Hooymans, PM; Stockbrügger, RW; van Gennip, A1
Allgayer, H; Kruis, W1
Banks, P; Bousvaros, A; Burakoff, R; Friedman, S; Hande, S; Makrauer, F; Maurer, R; Reddy, S; Wilson-Rich, N; Zholudev, A1
Pierik, M; Rutgeerts, P; Vermeire, S; Vlietinck, R1
Cuffari, C1
Araki, A; Chin, S; Ishii, K; Itsui, Y; Kanai, T; Kawamura, T; Kubota, D; Matsumoto, T; Miyata, T; Okada, E; Oooka, S; Sakamoto, N; Takishima, C; Tsuchiya, K; Watanabe, M1
Cottone, M; Modesto, I; Orlando, A; Scimeca, D1
Choudhary, C; Cohn, JR; Kung, SJ; McGeady, SJ1
Boubaker, J; Filali, A; Kallel, L; Karoui, S1
Abadom, V; Cuffari, C; Oliva-Hemker, MM; Thompson, RE1
Dilger, K; Herfarth, H; Lukas, M; Müller, R; Schaeffeler, E; Schwab, M; Strauch, U1
Christensen, LA; Nørgård, B; Pedersen, L; Sørensen, HT1
Burakoff, R; Levine, JS1
Baldassano, RN; Davis, CM; Hommel, KA1
Kornbluth, A; Swaminath, A1
Bandow, GD; Klekotka, PA; Wanat, KA1
Burakoff, R1
Mayberry, H; Mayberry, JF; Moshkovska, T1
Rogler, G; Vavricka, SR1
Feller, ER; Harris, A; Shah, SA1
Best, C; Sudel, B1
Esposti, SD; Saha, S1
Canaparo, R; Castagno, F; Crocellà, L; D'Antico, S; Daperno, M; Ercole, E; Lavagna, A; Pera, A; Rigazio, C; Rocca, R; Serpe, L; Sostegni, R; Vernetto, A; Zara, G1
Sandborn, WJ1
Greenley, RN; Hommel, KA; Kunz, JH1
Baldassano, RN; Hommel, KA1
Abe, J; Arai, O; Hanai, H; Hosoda, Y; Iida, T; Ikeya, K; Kageoka, M; Kubota, T; Maruyama, Y; Miwa, I; Oohata, A; Takeuchi, K; Watanabe, F; Yoshirou, S1
Das, K; Pitchumoni, CS; Rubin, A1
Al-Hassi, HO; Guenther, T; Hart, AL; Kamm, MA; Knight, SC; Ng, SC; Plamondon, S; Stagg, AJ1
Andrejic, J; Berkelhammer, C; Dennis, M; Rojas-Balcazar, J1
Bourke, B; Cortelazzo, S; Piccin, A; Rovigatti, U; Smith, OP1
de Boer, NK; de Graaf, P; Hooymans, PM; Jharap, B; Karner, S; Mulder, CJ; Schwab, M; van Bodegraven, AA; Veldkamp, AI; Wong, DR1
Cheung, DY; Cho, SH; Han, JY; Jun, EJ; Kim, JI; Kim, JK; Kim, TH; Lee, IK; Noh, CH; Park, SH1
Regueiro, M; Schwartz, M1
Gisbert, JP; Gomollón, F; Hinojosa, J; López San Román, A1
Bousvaros, A; Crandall, W; Evans, J; Griffiths, A; Grossman, A; Hyams, JS; Kappelman, MD; Kay, M; Keljo, D; Leleiko, N; Lerer, T; Mack, D; Markowitz, J; Michail, S; Oliva-Hemker, M; Otley, A; Pfefferkorn, M; Rosh, J; Saeed, S; Samson, C; Stephens, M; Sudel, B1
Denson, LA; Hente, E; Herzer, M; Hommel, KA; Ingerski, LM2
Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C1
Oldenburg, B; Siersema, PD; Smeets, HM; van der Heijden, GJ; van Oijen, MG; van Schaik, FD1
Jakobsen, C; Munkholm, P; Paerregaard, A; Wewer, V1
Cheifetz, AS; Doherty, GA; Miksad, RA; Moss, AC1
Meier, J; Sturm, A1
Cassano, R; Cilea, A; Ferrarelli, T; Muzzalupo, R; Picci, N; Trombino, S1
Chaparro, M; Gisbert, JP; Gomollón, F1
Denson, LA; Guilfoyle, SM; Hente, EA; Herzer, M; Hommel, KA; Ingerski, LM; Odell, S1
Bigard, MA; Billioud, V; Bresler, L; Chevaux, JB; Gueant, JL; Oussalah, A; Peyrin-Biroulet, L; Pillot, C; Williet, N1
Balogh, M; David, G; Erdelyi, Z; Golovics, PA; Horvath, A; Kiss, LS; Komaromi, E; Lakatos, L; Lakatos, PL; Lovasz, BD; Mester, G; Molnar, C; Pandur, T; Szathmari, M; Szipocs, I; Veres, G1
Stiefelhagen, P1
Cheon, JH; Choi, CH; Jang, BI; Kim, YH; Lee, H; Lee, KM; Shin, SJ; Yang, SK; Ye, BD1
Dijkstra, G; Nieuwenhuijs, VB; Ploeg, RJ; van Loo, ES1
Assulin, Y; Beer-Gabel, M; Chowers, Y; Lahat, A1
Armuzzi, A; D'Haens, G; Griffiths, A; Lukas, M; Pineton de Chambrun, G; Preiss, JC; Reinisch, W; Sladek, M; Van Assche, G1
Hirata, Y; Joh, T; Kamiya, T; Kataoka, H; Mizoshita, T; Mizushima, T; Murakami, K; Ozeki, K; Shimura, T; Tanida, S; Tsukamoto, H1
Balogh, M; Dávid, G; Erdélyi, Z; Golovics, PA; Horváth, A; Kiss, LS; Komáromi, E; Lakatos, L; Lakatos, PL; Lovász, BD; Mester, G; Molnár, C; Pandur, T; Szathmári, M; Szipocs, I1
Abe, J; Arai, H; Arai, O; Hanai, H; Iida, T; Ikeya, K; Maruyama, Y; Nakamura, K; Nakamura, T; Sugimoto, K; Takeuchi, K; Tanaka, T; Watanabe, F1
Kelly, S1
Bi, HC; Chen, BL; Chen, MH; Ding, L; Gao, X; Hu, PJ; Huang, M; Liu, H; Wang, XD; Xiao, YL; Zhang, FB; Zhao, LZ1
Basit, S; Jess, T; Langholz, E; Ranthe, MF; Rungoe, C; Wohlfahrt, J1
Macdonald, JK; McDonald, JW; Timmer, A; Tsoulis, DJ1
Hibi, T; Yajima, T1
Fangbin, Z; Feng, X; Liang, D; Min, H; Minhu, C; Pinjin, H; Xiang, G1
Aldeguer, X; Busquets, D1
Watanabe, T; Yamamoto, T1
Ban, L; Card, T; Fiaschi, L; Tata, LJ1
Ruemmele, FM; Turner, D1
Blonski, W; Buchner, AM; Lichtenstein, GR1
Rogler, G; Scharl, M; Schoepfer, AM; Vavricka, SR1
Chapman, CG; Rubin, DT1
Deepak, P; Stobaugh, DJ1
Akobeng, AK; Gordon, M; Taylor, K; Thomas, AG1
Chande, N; MacDonald, JK; McDonald, JW; Wang, Y1
de Boer, NK; Tack, GJ; Waayenberg, P1
Carla-Moreau, A; Genin, C; Paul, S; Peyrin-Biroulet, L; Roblin, X1
Cuzzoni, E; De Iudicibus, S; Decorti, G; Favretto, D; Lionetti, P; Malusà, N; Martelossi, S; Pozzi, E; Stocco, G; Ventura, A1
Broekman, MM; de Jong, DJ; Hoentjen, F; Kerstholt, M; Leijten, A; Peters, WH; Roelofs, HM; Wanten, GJ; Wong, DR1
El-Matary, W; Griffiths, AM; MacDonald, JK; Vandermeer, B; Wang, Y1
Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R1
Chande, N; MacDonald, JK; McDonald, JW; Patton, PH; Timmer, A1
de Lima-Karagiannis, A; van der Woude, CJ; Zelinkova-Detkova, Z1
Ghazi, LJ; Latushko, A1
Chande, N; MacDonald, JK; Parker, CE; Townsend, CM1
Siegmund, B; Sonnenberg, E1
Boice, J; Colombel, JF; Cornillie, F; D'Haens, G; Ghosh, S; Hommes, DW; Huang, Z; Huyck, S; Lindgren, S; Panes, J; Prantera, C; Reinisch, W1
Choi, CH; Han, DS; Jung, Y; Kim, ES; Kim, YS; Lee, BI; Lee, H; Moon, W; Park, DI; Yoon, YS1
Im, JP; Kim, JW; Lee, H; Lee, KM; Park, DI; Park, JJ; Yang, SK; Ye, BD; Yoon, H; Yoon, SN1
Allocca, M; Armuzzi, A; Bonovas, S; Danese, S; Fiorino, G; Furfaro, F; Landi, R; Papa, A; Peyrin-Biroulet, L; Spinelli, A1
Kandolf-Sekulović, L; Mijušković, Ž; Milenković, Z; Pecelj-Broćić, T; Tarabar, D; Tarabar, O; Tatomirović, Ž1
Andoh, A; Araki, H; Endo, K; Hanai, H; Hiraoka, S; Hisamatsu, T; Hokari, R; Ikeya, K; Ishiguro, Y; Kakuta, Y; Kawai, Y; Kinouchi, Y; Kobayashi, T; Masamune, A; Matsumoto, T; Miura, M; Mizuno, S; Moroi, R; Motoya, S; Naganuma, M; Nagasaki, M; Naito, T; Nakagawa, S; Nakagawa, T; Nakamura, S; Nakase, H; Nishida, A; Okamoto, D; Onodera, K; Sakuraba, H; Sasaki, M; Shiga, H; Shimosegawa, T; Shinozaki, M; Suzuki, Y; Takagawa, T; Takahara, M; Toyonaga, T; Yanai, S1
Akobeng, AK; Gordon, M; MacDonald, JK; Zhang, D1
Dulai, PS1
Carlson, M; Eberhardson, M; Hedin, CRH; Levine, YA; Olofsson, PS; Tarnawski, L1
Andoh, A; Bamba, S; Inatomi, O; Kawahara, M; Morita, Y; Nishida, A; Sasaki, M; Sugimoto, M; Takahashi, K1
Figueroa Corona, C; Flores Pérez, L; Ibáñez Lazo, P; Quera Pino, R; Sedano Muñoz, R1
Abbass, M; Cepek, J; Feagan, BG; Jairath, V; Khanna, R; MacDonald, JK; Nguyen, TM; Parker, CE; Townsend, CM1
Hibi, T; Hisamatsu, T; Ikezaki, O; Kiyohara, H; Kobayashi, T; Kuronuma, S; Matsubayashi, M; Morikubo, H; Nakano, M; Okabayashi, S; Ozaki, R; Sagami, S; Shiba, T; Takeuchi, O; Tanaka, Y1
Clasquin, E; D'Haens, G; de Boer, N; Dijkgraaf, M; Duijvestein, M; Jansen, J; Löwenberg, M; Montazeri, N; Mookhoek, A; Rietdijk, S; van Asseldonk, D; van Bodegraven, A; van der Zanden, E; van Gennep, S; Volkers, A; West, R1

Reviews

46 review(s) available for mesalamine and mercaptopurine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Drug therapy of chronic inflammatory bowel disease--reliable standards and new developments].
    Leber, Magen, Darm, 1992, Volume: 22, Issue:2

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Sulfasalazine

1992
Maintenance treatment for Crohn's disease: has the time arrived?
    The American journal of gastroenterology, 1992, Volume: 87, Issue:5

    Topics: Aminosalicylic Acids; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mercaptopurine; Mesalamine; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Sulfasalazine

1992
[Conservative therapy of ulcerative colitis--long-term experience].
    Der Internist, 1991, Volume: 32, Issue:9

    Topics: Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Glucocorticoids; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Prognosis; Sulfasalazine

1991
Maintenance of symptomatic remission in patients with Crohn's disease.
    Mayo Clinic proceedings, 1993, Volume: 68, Issue:12

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine

1993
Medical therapy for ulcerative colitis in childhood.
    Seminars in pediatric surgery, 1994, Volume: 3, Issue:1

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Child; Child, Preschool; Clinical Trials as Topic; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Humans; Infant; Intestinal Mucosa; Mercaptopurine; Mesalamine; Sulfasalazine

1994
Medical management of patients with difficult-to-treat inflammatory bowel disease.
    The Netherlands journal of medicine, 1994, Volume: 45, Issue:2

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole

1994
Crohn's disease and acute leukocytoclastic vasculitis of skin.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:11

    Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Vessels; Crohn Disease; Humans; Hydrocortisone; Male; Mercaptopurine; Mesalamine; Prednisone; Vasculitis, Leukocytoclastic, Cutaneous

1996
Drug prophylaxis of recurrence of Crohn's disease after resection: the way to go.
    Italian journal of gastroenterology and hepatology, 1998, Volume: 30, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Digestive System Surgical Procedures; Humans; Interleukin-10; Mercaptopurine; Mesalamine; Prognosis; Randomized Controlled Trials as Topic; Secondary Prevention

1998
Conventional treatment of Crohn's disease: objectives and outcomes.
    Inflammatory bowel diseases, 2001, Volume: 7 Suppl 1

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Methotrexate; Prednisone; Quality of Life; Recurrence; Sulfasalazine; Treatment Outcome

2001
Medical management of ulcerative proctitis, proctosigmoiditis, and left-sided colitis.
    Seminars in gastrointestinal disease, 2001, Volume: 12, Issue:4

    Topics: Administration, Oral; Administration, Rectal; Administration, Topical; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Prednisone; Proctocolitis; Sigmoidoscopy

2001
Review article: maintenance of remission in ulcerative colitis.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16 Suppl 4

    Topics: Administration, Oral; Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Remission Induction

2002
[Conservative therapy of inflammatory bowel diseases].
    Orvosi hetilap, 2002, Dec-15, Volume: 143, Issue:50

    Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Prednisolone; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine

2002
[Management of ulcerative colitis].
    Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:3

    Topics: Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anemia; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antiviral Agents; Azathioprine; Budesonide; Clinical Trials as Topic; Colectomy; Colitis, Ulcerative; Colonic Pouches; Colonoscopy; Colorectal Neoplasms; Cyclosporins; Gastrointestinal Agents; Humans; Hydrocortisone; Immunosuppressive Agents; Infliximab; Injections, Intravenous; Interferons; Mercaptopurine; Mesalamine; Osteoporosis; Placebos; Practice Guidelines as Topic; Recurrence; Remission Induction; Risk Factors; Suppositories; Time Factors

2003
Ulcerative colitis: conservative management and long-term effects.
    Langenbeck's archives of surgery, 2004, Volume: 389, Issue:5

    Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colectomy; Colitis, Ulcerative; Cyclosporins; Double-Blind Method; Follow-Up Studies; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Interferon-beta; Mercaptopurine; Mesalamine; Pilot Projects; Placebos; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors; Treatment Outcome

2004
Review article: chronic active disease and maintaining remission in Crohn's disease.
    Alimentary pharmacology & therapeutics, 2004, Volume: 20 Suppl 4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chronic Disease; Crohn Disease; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Prognosis; Steroids; Thalidomide

2004
[Guidelines for treatment of ulcerative colitis in children].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63, Issue:5

    Topics: Azathioprine; Child; Colitis, Ulcerative; Contraindications; Cyclosporins; Growth Disorders; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Practice Guidelines as Topic; Prednisolone; Pulse Therapy, Drug; Quality of Life

2005
Pharmacogenetics in inflammatory bowel disease.
    World journal of gastroenterology, 2006, Jun-21, Volume: 12, Issue:23

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Methyltransferases; Pharmacogenetics; Polymorphism, Genetic; Sulfasalazine; Treatment Outcome

2006
Inflammatory bowel disease in children: a pediatrician's perspective.
    Minerva pediatrica, 2006, Volume: 58, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Child; Colitis, Ulcerative; Environment; Genetic Predisposition to Disease; Humans; Ileus; Immunoglobulin A; Immunoglobulin G; Inflammatory Bowel Diseases; Intracellular Signaling Peptides and Proteins; Mass Screening; Mercaptopurine; Mesalamine; Nod2 Signaling Adaptor Protein; Risk Factors

2006
[Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
    La Tunisie medicale, 2006, Volume: 84, Issue:10

    Topics: Algorithms; Anastomosis, Surgical; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colon; Crohn Disease; Endoscopy; Female; Humans; Ileum; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Metronidazole; Odds Ratio; Randomized Controlled Trials as Topic; Risk; Risk Factors; Secondary Prevention; Smoking; Time Factors

2006
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.
    Inflammatory bowel diseases, 2007, Volume: 13, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colorectal Neoplasms; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Treatment Outcome; Ursodeoxycholic Acid; Vitamin B Complex

2007
Optimizing drug therapy in inflammatory bowel disease.
    Current gastroenterology reports, 2007, Volume: 9, Issue:6

    Topics: Absorptiometry, Photon; Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Cyclosporine; Humans; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Mesalamine; Patient Compliance; Prednisone; Treatment Failure

2007
[Treatment of Crohn's disease].
    Praxis, 2009, Jan-21, Volume: 98, Issue:2

    Topics: Adrenal Cortex Hormones; Azathioprine; Biological Products; Colectomy; Combined Modality Therapy; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Methotrexate

2009
Reproductive issues in inflammatory bowel disease.
    Medicine and health, Rhode Island, 2009, Volume: 92, Issue:4

    Topics: Adaptation, Psychological; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Humans; Immunosuppressive Agents; Infertility, Female; Infertility, Male; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Pregnancy; Pregnancy Complications; Reproductive Behavior; Stress, Psychological; Sulfasalazine

2009
The future of inflammatory bowel disease care.
    Reviews in gastroenterological disorders, 2009,Summer, Volume: 9, Issue:3

    Topics: Adalimumab; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Clinical Trials as Topic; Gastrointestinal Agents; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Mesalamine; Natalizumab; Polyethylene Glycols; Tumor Necrosis Factor-alpha

2009
Pancreatitis in inflammatory bowel diseases.
    Journal of clinical gastroenterology, 2010, Volume: 44, Issue:4

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Pancreatitis; Sulfasalazine

2010
Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade.
    Current gastroenterology reports, 2011, Volume: 13, Issue:1

    Topics: Adalimumab; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colonoscopy; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Mercaptopurine; Mesalamine; Postoperative Care; Probiotics; Risk Factors; Secondary Prevention; Tumor Necrosis Factor-alpha

2011
Current treatment of ulcerative colitis.
    World journal of gastroenterology, 2011, Jul-21, Volume: 17, Issue:27

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Endoscopy; Gastroenterology; Humans; Infliximab; Mercaptopurine; Mesalamine; Remission Induction; Steroids; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha

2011
Prevention of postoperative recurrence of Crohn's disease.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:6

    Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Interleukin-10; Intestine, Small; Laparoscopy; Mercaptopurine; Mesalamine; Nitroimidazoles; Probiotics; Secondary Prevention; Treatment Outcome

2012
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    The Cochrane database of systematic reviews, 2012, Sep-12, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfasalazine

2012
Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013, Volume: 15, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colectomy; Colon; Colonoscopy; Crohn Disease; Humans; Ileum; Immunosuppressive Agents; Infliximab; Intestinal Perforation; Mercaptopurine; Mesalamine; Nitroimidazoles; Odds Ratio; Proportional Hazards Models; Risk Factors; Secondary Prevention; Smoking; Treatment Outcome

2013
Treatment of ulcerative colitis.
    Current opinion in gastroenterology, 2014, Volume: 30, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha

2014
Steroid use in Crohn's disease.
    Drugs, 2014, Volume: 74, Issue:3

    Topics: Adrenal Cortex Hormones; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha

2014
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
    Gastrointestinal endoscopy clinics of North America, 2014, Volume: 24, Issue:3

    Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid

2014
Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    The Cochrane database of systematic reviews, 2014, Aug-01, Issue:8

    Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Remission Induction; Secondary Prevention

2014
Methotrexate for induction of remission in ulcerative colitis.
    The Cochrane database of systematic reviews, 2014, Aug-27, Issue:8

    Topics: Administration, Oral; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Induction Chemotherapy; Mercaptopurine; Mesalamine; Methotrexate; Randomized Controlled Trials as Topic

2014
Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Observational Studies as Topic; Odds Ratio; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Secondary Prevention; Treatment Outcome; Tumor Necrosis Factor-alpha

2015
Methotrexate for maintenance of remission in ulcerative colitis.
    The Cochrane database of systematic reviews, 2015, Aug-11, Issue:8

    Topics: Administration, Oral; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Methotrexate; Sulfasalazine

2015
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    The Cochrane database of systematic reviews, 2016, May-18, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention; Sulfasalazine

2016
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    The Cochrane database of systematic reviews, 2016, Oct-26, Volume: 10

    Topics: Adult; Antimetabolites; Azathioprine; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Mercaptopurine; Mesalamine; Prednisone; Randomized Controlled Trials as Topic; Sulfasalazine; Withholding Treatment

2016
[Second Korean Guideline for the Management of Ulcerative Colitis].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2017, Jan-25, Volume: 69, Issue:1

    Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; C-Reactive Protein; Colitis, Ulcerative; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Parenteral Nutrition; Prednisolone; Severity of Illness Index; Steroids; Tumor Necrosis Factor-alpha

2017
[Second Korean Guidelines for the Management of Crohn's Disease].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2017, Jan-25, Volume: 69, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Crohn Disease; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Severity of Illness Index; Tumor Necrosis Factor-alpha

2017
Enteral nutrition for maintenance of remission in Crohn's disease.
    The Cochrane database of systematic reviews, 2018, 08-11, Volume: 8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Crohn Disease; Diet; Enteral Nutrition; Food, Formulated; Humans; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Randomized Controlled Trials as Topic; Secondary Prevention

2018
Towards improved control of inflammatory bowel disease.
    Scandinavian journal of immunology, 2019, Volume: 89, Issue:3

    Topics: Antibodies, Monoclonal; Electric Stimulation Therapy; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha; Vagus Nerve

2019
Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
    Gastroenterologia y hepatologia, 2019, Volume: 42, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Withholding Treatment

2019
Adalimumab for maintenance of remission in Crohn's disease.
    The Cochrane database of systematic reviews, 2020, May-16, Volume: 5

    Topics: Adalimumab; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Drug Administration Schedule; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Middle Aged; Patient Dropouts; Placebos; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult

2020

Trials

14 trial(s) available for mesalamine and mercaptopurine

ArticleYear
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:12

    Topics: Abdominal Pain; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chronic Disease; Crohn Disease; Double-Blind Method; Evaluation Studies as Topic; Female; Follow-Up Studies; Health Status; Humans; Immunosuppressive Agents; Israel; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Placebos; Recurrence; Remission Induction; Treatment Outcome

1997
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.
    Gastroenterology, 2000, Volume: 118, Issue:4

    Topics: Adolescent; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Genotype; Humans; Immunosuppressive Agents; Infant; Inflammatory Bowel Diseases; Leukopenia; Liver; Male; Mercaptopurine; Mesalamine; Methyltransferases; Prospective Studies; Thioguanine; Treatment Outcome

2000
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
    Gastroenterology, 2004, Volume: 127, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Digestive System Surgical Procedures; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Postoperative Period; Remission Induction; Secondary Prevention; Survival Analysis; Treatment Outcome

2004
The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients.
    Alimentary pharmacology & therapeutics, 2005, Oct-01, Volume: 22, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Prospective Studies; Thioguanine

2005
Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: clinical response without endoscopic response.
    Inflammatory bowel diseases, 2006, Volume: 12, Issue:10

    Topics: Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Male; Mercaptopurine; Mesalamine; Middle Aged; Remission Induction; Treatment Failure; Treatment Outcome

2006
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Therapeutic drug monitoring, 2007, Volume: 29, Issue:1

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Female; Gene Frequency; Genotype; Guanine Nucleotides; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Phenotype; Postoperative Period; Prospective Studies; Thioguanine; Thionucleotides; Time Factors

2007
Thiopurine maintenance therapy for ulcerative colitis: the clinical significance of monitoring 6-thioguanine nucleotide.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Marrow Diseases; Colitis, Ulcerative; Drug Monitoring; Erythrocytes; Humans; Immunosuppressive Agents; Leukapheresis; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Prednisolone; Thioguanine; Treatment Outcome; Young Adult

2010
Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:8

    Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; B7-2 Antigen; CD40 Antigens; Colitis, Ulcerative; Colon; Dendritic Cells; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interleukin-10; Interleukin-12 Subunit p40; Interleukin-13; Interleukin-6; Male; Mercaptopurine; Mesalamine; Middle Aged; Probiotics; Receptors, Pattern Recognition; Young Adult

2010
Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy.
    British journal of pharmacology, 2010, Volume: 160, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Prospective Studies

2010
Individually tailored treatment of medication nonadherence.
    Journal of pediatric gastroenterology and nutrition, 2011, Volume: 53, Issue:4

    Topics: Adolescent; Azathioprine; Child; Feasibility Studies; Female; Humans; Inflammatory Bowel Diseases; Interviews as Topic; Male; Medication Adherence; Mercaptopurine; Mesalamine; Patient Education as Topic; Pilot Projects; Precision Medicine; Surveys and Questionnaires; Treatment Outcome

2011
Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease.
    European journal of gastroenterology & hepatology, 2012, Volume: 24, Issue:1

    Topics: Adolescent; Adolescent Behavior; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behavior Therapy; Caregivers; Child; Drug Administration Schedule; Drug Combinations; Epidemiologic Methods; Family Therapy; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Medication Adherence; Mercaptopurine; Mesalamine; Middle Aged; Self Administration; United States

2012
Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012, Volume: 44, Issue:8

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Food, Formulated; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Longitudinal Studies; Maintenance Chemotherapy; Male; Mercaptopurine; Mesalamine; Recurrence; Young Adult

2012
Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study.
    European journal of gastroenterology & hepatology, 2013, Volume: 25, Issue:4

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behavior Therapy; Child; Cost of Illness; Delivery of Health Care; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Medication Adherence; Mercaptopurine; Mesalamine; Ohio; Pilot Projects; Severity of Illness Index; Telemedicine; Treatment Outcome

2013
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial.
    Journal of Crohn's & colitis, 2023, Jul-05, Volume: 17, Issue:7

    Topics: Colitis, Ulcerative; Humans; Mercaptopurine; Mesalamine; Prospective Studies; Remission Induction

2023

Other Studies

82 other study(ies) available for mesalamine and mercaptopurine

ArticleYear
Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.
    Gut, 1996, Volume: 39, Issue:1

    Topics: Administration, Oral; Administration, Rectal; Adult; Azathioprine; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged

1996
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Animals; Azathioprine; Bacteriological Techniques; Cattle; Cattle Diseases; Colony Count, Microbial; Crohn Disease; Culture Media; Humans; Immunosuppressive Agents; Mercaptopurine; Microbial Sensitivity Tests; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Reagent Kits, Diagnostic

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Immunology of inflammatory bowel disease: summary of the proceedings of the Subcommittee on Immunosuppressive Use in IBD.
    Journal of pediatric gastroenterology and nutrition, 1991, Volume: 12, Issue:4

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lipoxygenase Inhibitors; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole; Steroids

1991
Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.
    British journal of clinical pharmacology, 1995, Volume: 39, Issue:4

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Binding, Competitive; Drug Interactions; Gallic Acid; Humans; Kinetics; Mercaptopurine; Mesalamine; Methylation; Methyltransferases; Pyridines; Recombinant Proteins; Substrate Specificity; Sulfapyridine; Sulfasalazine

1995
6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:9

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Colitis, Ulcerative; Humans; Mercaptopurine; Mesalamine; Steroids; Time Factors

1996
The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:9

    Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Colitis, Ulcerative; Female; Humans; Life Tables; Male; Mercaptopurine; Mesalamine; Prednisone; Recurrence; Remission Induction; Time Factors; Treatment Outcome

1996
An unusual complication of immunosuppressive therapy in inflammatory bowel disease.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:9

    Topics: Aged; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Betamethasone; Bronchoalveolar Lavage Fluid; Colitis, Ulcerative; Fatal Outcome; Glucocorticoids; HIV Seronegativity; Humans; Immunity, Cellular; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Opportunistic Infections; Pneumonia, Pneumocystis; Prednisolone; Sulfasalazine

1997
5-aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells.
    Gut, 1999, Volume: 44, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Culture Techniques; Colon; Dose-Response Relationship, Drug; Epithelial Cells; Free Radical Scavengers; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hypochlorous Acid; Mercaptopurine; Mesalamine; Methylprednisolone; Metronidazole; Oxidants; Oxidative Stress

1999
Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction.
    Gastroenterology, 1999, Volume: 116, Issue:6

    Topics: Aminosalicylic Acids; Anti-Ulcer Agents; Antirheumatic Agents; Azathioprine; Drug Interactions; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Phenylhydrazines

1999
Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:11

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Confidence Intervals; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Probability; Proportional Hazards Models; Recurrence; Remission Induction; Sex Factors; Time Factors

1999
Balsalazide and azathioprine or 6-mercaptopurine.
    Gastroenterology, 1999, Volume: 117, Issue:6

    Topics: Administration, Oral; Aminosalicylic Acids; Antimetabolites; Azathioprine; Drug Interactions; Humans; Inhibitory Concentration 50; Mercaptopurine; Mesalamine; Methyltransferases; Phenylhydrazines; Prodrugs

1999
Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents.
    Gastroenterology, 2000, Volume: 119, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Drug Interactions; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine

2000
Crohn's disease presenting with Henoch-Schönlein purpura.
    Journal of pediatric gastroenterology and nutrition, 2000, Volume: 31, Issue:2

    Topics: Adolescent; Biopsy; Blood Vessels; Colon; Complement C3; Crohn Disease; Dapsone; Endoscopy, Gastrointestinal; Female; Humans; IgA Vasculitis; Immunoglobulin A; Immunoglobulin M; Mercaptopurine; Mesalamine; Prednisone; Skin; Vasculitis

2000
Crohn's disease of the esophagus: clinical features and outcomes.
    Inflammatory bowel diseases, 2001, Volume: 7, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Child; Child, Preschool; Crohn Disease; Data Interpretation, Statistical; Dilatation; Esophageal Diseases; Esophagoscopy; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Steroids

2001
Glucocorticoids and IL-10, but not 6-MP, 5-ASA or sulfasalazine block endothelial expression of MAdCAM-1: implications for inflammatory bowel disease therapy.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion Molecules; Cells, Cultured; Dexamethasone; Endothelium; Glucocorticoids; Immunoglobulins; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-10; Lymphocytes; Mercaptopurine; Mesalamine; Mice; Mucoproteins; Reverse Transcriptase Polymerase Chain Reaction; Sulfasalazine; Thymidine Kinase; Tumor Necrosis Factor-alpha

2001
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.
    Gut, 2001, Volume: 49, Issue:5

    Topics: Adult; Aminosalicylic Acids; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Binomial Distribution; Chromatography, High Pressure Liquid; Confidence Intervals; Drug Interactions; Female; Humans; Immunosuppressive Agents; Leukopenia; Male; Mercaptopurine; Mesalamine; Methyltransferases; Phenylhydrazines; Sulfasalazine; Thioguanine

2001
[Acute episode].
    Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:1

    Topics: Acute Disease; Adult; Age Factors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Child; Controlled Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Nutritional Physiological Phenomena; Prednisolone; Time Factors

2003
[Maintaining a remission].
    Zeitschrift fur Gastroenterologie, 2003, Volume: 41, Issue:1

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Methotrexate; Placebos; Postoperative Care; Prednisolone; Pregnancy; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Risk Factors; Time Factors

2003
Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Intestinal Fistula; Male; Medical Records; Mercaptopurine; Mesalamine; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome

2003
Severe gastrointestinal illness associated with olestra ingestion.
    Journal of pediatric gastroenterology and nutrition, 2003, Volume: 37, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Child; Colectomy; Fatty Acids; Female; Gastrointestinal Diseases; Humans; Male; Mercaptopurine; Mesalamine; Prednisone; Sucrose

2003
6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
    Gastroenterology, 2005, Volume: 128, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Secondary Prevention

2005
Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model.
    Pharmaceutical research, 2005, Volume: 22, Issue:8

    Topics: Algorithms; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport, Active; Caco-2 Cells; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Colitis; Drug Carriers; Drug Compounding; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Absorption; Liposomes; Male; Mercaptopurine; Mesalamine; Rats; Rats, Sprague-Dawley

2005
Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2006, Volume: 4, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Azathioprine; Colitis, Ulcerative; Colorectal Neoplasms; Humans; Mercaptopurine; Mesalamine

2006
5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Inflammatory bowel diseases, 2006, Volume: 12, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Child; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Remission Induction; Retrospective Studies; Severity of Illness Index; Thioguanine; Treatment Outcome

2006
[A case report: Severe bone marrow suppression caused by 6-mercaptopurin in Crohn's disease patient].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2006, Volume: 103, Issue:9

    Topics: Abscess; Adult; Anus Diseases; Bone Marrow; Crohn Disease; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Humans; Ileitis; Immunosuppressive Agents; Leukocyte Count; Male; Mercaptopurine; Mesalamine; Neutropenia

2006
Lack of cross-reactivity between 5-aminosalicylic acid-based drugs: a case report and review of the literature.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 97, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Cross Reactions; Drug Hypersensitivity; Exanthema; Herpes Simplex; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Phenylhydrazines; Prednisone

2006
Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease.
    Journal of pediatric gastroenterology and nutrition, 2007, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Crohn Disease; Cross-Sectional Studies; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Prevalence; Treatment Refusal

2007
Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
    The American journal of gastroenterology, 2007, Volume: 102, Issue:7

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Confidence Intervals; Congenital Abnormalities; Crohn Disease; Denmark; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Infant, Newborn; Male; Mercaptopurine; Mesalamine; Population Surveillance; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Risk Factors; Sulfasalazine

2007
Medication adherence and quality of life in pediatric inflammatory bowel disease.
    Journal of pediatric psychology, 2008, Volume: 33, Issue:8

    Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Guanine Nucleotides; Humans; Illness Behavior; Male; Medication Adherence; Mercaptopurine; Mesalamine; Quality of Life; Thionucleotides

2008
Palmar-plantar erythrodysesthesia caused by mercaptopurine and mesalamine.
    Archives of dermatology, 2008, Volume: 144, Issue:8

    Topics: Acrodermatitis; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Crohn Disease; Drug Eruptions; Drug Interactions; Drug Therapy, Combination; Female; Humans; Mercaptopurine; Mesalamine; Methyltransferases; Mucous Membrane; Paresthesia; Skin

2008
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
    Inflammatory bowel diseases, 2008, Volume: 14 Suppl 2

    Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome

2008
Co-prescribing azathiopurine or 6-mercaptopurine and 5-aminosalicylate compounds in ulcerative colitis.
    Inflammatory bowel diseases, 2009, Volume: 15, Issue:2

    Topics: Adult; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Practice Patterns, Physicians'; Treatment Outcome

2009
Medical therapy of IBD in 2009.
    Medicine and health, Rhode Island, 2009, Volume: 92, Issue:3

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Natalizumab; Probiotics; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha

2009
Bone marrow suppression in the setting of normal thiopurine methyltransferase phenotype testing.
    Clinical pediatrics, 2010, Volume: 49, Issue:9

    Topics: Adolescent; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow; Crohn Disease; Drug Hypersensitivity; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Methyltransferases; Pancytopenia; Phenotype; Purine-Pyrimidine Metabolism, Inborn Errors

2010
Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
    Alimentary pharmacology & therapeutics, 2009, Oct-15, Volume: 30, Issue:8

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; DNA; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Prospective Studies; Young Adult

2009
Health-related quality of life of youth with inflammatory bowel disease: a comparison with published data using the PedsQL 4.0 generic core scales.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Child; Female; Humans; Inflammatory Bowel Diseases; Interpersonal Relations; Male; Mercaptopurine; Mesalamine; Methylthioinosine; Middle Aged; Parents; Quality of Life; Self Concept; Severity of Illness Index; Sickness Impact Profile; Social Adjustment; Thioguanine

2010
Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease.
    Journal of pediatric psychology, 2010, Volume: 35, Issue:9

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interviews as Topic; Male; Medication Adherence; Mercaptopurine; Mesalamine; Severity of Illness Index; Social Environment

2010
Azathioprine-induced hypersensitivity hepatitis: tolerance to 6-mercaptopurine.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:11

    Topics: Acute Disease; Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Drug Hypersensitivity; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Prednisolone; Treatment Outcome

2010
Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia.
    American journal of hematology, 2010, Volume: 85, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Budesonide; Chromosomes, Human, Pair 7; Combined Modality Therapy; Crohn Disease; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Monocytic, Acute; Male; Mercaptopurine; Mesalamine; Methyltransferases; Monosomy; Myelodysplastic Syndromes; Prednisone; Young Adult

2010
[Remission of ulcerative colitis after appendectomy: a case report].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2010, Volume: 56, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Appendectomy; Colitis, Ulcerative; Colonoscopy; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Tomography, X-Ray Computed; Treatment Outcome

2010
Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain.
    Journal of Crohn's & colitis, 2010, Volume: 4, Issue:5

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Colitis, Ulcerative; Cross-Sectional Studies; Europe; Gastroenterology; Guideline Adherence; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Spain; Surveys and Questionnaires

2010
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.
    The American journal of gastroenterology, 2011, Volume: 106, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Treatment Outcome

2011
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
    Journal of Crohn's & colitis, 2011, Volume: 5, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus

2011
Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
    Gut, 2012, Volume: 61, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cohort Studies; Colorectal Neoplasms; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Proportional Hazards Models; Risk

2012
Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators--a population-based study.
    Inflammatory bowel diseases, 2011, Volume: 17, Issue:8

    Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Denmark; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Male; Mercaptopurine; Mesalamine; Remission Induction; Time Factors; Treatment Outcome

2011
Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.
    Inflammatory bowel diseases, 2012, Volume: 18, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Cost-Benefit Analysis; Crohn Disease; Decision Trees; Health Care Costs; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Monte Carlo Method; Postoperative Period; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Secondary Prevention

2012
Synthesis of pro-prodrugs L-lysine based for 5-aminosalicylic acid and 6-mercaptopurine colon specific release.
    International journal of pharmaceutics, 2011, Nov-28, Volume: 420, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Colon; Gastric Juice; Hydrophobic and Hydrophilic Interactions; Immunosuppressive Agents; Intestinal Secretions; Lipid Peroxidation; Lysine; Malondialdehyde; Mercaptopurine; Mesalamine; Microsomes, Liver; Microspheres; Prodrugs; Rats; Rats, Wistar; Reactive Oxygen Species

2011
Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.
    World journal of gastroenterology, 2011, Aug-14, Volume: 17, Issue:30

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine

2011
Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics.
    Inflammatory bowel diseases, 2012, Volume: 18, Issue:9

    Topics: Adult; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Mesalamine; Prognosis; Prospective Studies; Referral and Consultation; Tumor Necrosis Factor-alpha; Young Adult

2012
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
    The American journal of gastroenterology, 2012, Volume: 107, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chi-Square Distribution; Cohort Studies; Crohn Disease; Female; Gastrointestinal Agents; Humans; Hungary; Immunosuppressive Agents; Incidence; Infliximab; Logistic Models; Male; Mercaptopurine; Mesalamine; Methotrexate; Phenotype; Proportional Hazards Models; Retrospective Studies; Steroids; Sulfasalazine; Surveys and Questionnaires

2012
[FAQs in chronic inflammatory bowel diseases. This way your patient stays in remission].
    MMW Fortschritte der Medizin, 2011, Dec-08, Volume: 153, Issue:49-50

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Diagnosis, Differential; General Practice; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Prognosis

2011
[Guidelines for the management of Crohn's disease].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 59, Issue:2

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn Disease; Databases, Factual; Female; Fistula; Humans; Infliximab; Intestinal Perforation; Male; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Pregnancy; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine

2012
Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:3

    Topics: Abscess; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Anus Diseases; Azathioprine; Ciprofloxacin; Crohn Disease; Cutaneous Fistula; Endosonography; Female; Humans; Immunosuppressive Agents; Incidental Findings; Infliximab; Male; Mercaptopurine; Mesalamine; Metronidazole; Middle Aged; Rectal Fistula; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult

2012
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:4

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Endoscopy, Gastrointestinal; Humans; Inflammatory Bowel Diseases; Infliximab; Intestinal Mucosa; Mercaptopurine; Mesalamine; Methotrexate; Treatment Outcome

2012
Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: a case report.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:6

    Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Colonoscopy; Combined Modality Therapy; Crohn Disease; Granulocytes; Humans; Immunosuppressive Agents; Leukapheresis; Leukocyte Reduction Procedures; Male; Mercaptopurine; Mesalamine; Metronidazole; Monocytes; Parenteral Nutrition, Total; Prednisolone; Remission Induction; Young Adult

2012
[The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].
    Orvosi hetilap, 2012, Apr-08, Volume: 153, Issue:14

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cohort Studies; Colectomy; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Hungary; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Time Factors; Treatment Failure

2012
Ulcerative colitis.
    BMJ (Clinical research ed.), 2012, May-10, Volume: 344

    Topics: Anecdotes as Topic; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colitis, Ulcerative; Diagnostic Errors; Disease Progression; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Patient Acceptance of Health Care; Recurrence; Shame; Students; Treatment Outcome; Young Adult

2012
The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.
    European journal of gastroenterology & hepatology, 2012, Volume: 24, Issue:8

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Azathioprine; Bone Marrow; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; Guanine Nucleotides; Humans; Immunosuppressive Agents; Infant; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Prospective Studies; Retrospective Studies; Thionucleotides; Young Adult

2012
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
    Gut, 2013, Volume: 62, Issue:5

    Topics: Adolescent; Adult; Aged; Atherosclerosis; Case-Control Studies; Cohort Studies; Denmark; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Myocardial Ischemia; Registries; Risk; Severity of Illness Index; Tumor Necrosis Factor-alpha

2013
[Chemoprevention of colorectal cancer associated with IBD].
    Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 1

    Topics: Azathioprine; Colorectal Neoplasms; Crohn Disease; Folic Acid; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine

2012
Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:6

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; China; Drug Interactions; Drug Monitoring; Female; Follow-Up Studies; Genetic Association Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Leukopenia; Male; Mercaptopurine; Mesalamine; Methyltransferases; Middle Aged; Mutation; Prospective Studies; Young Adult

2012
Clinical experience with adalimumab in anti-TNF-naïve patients with ulcerative colitis.
    Journal of Crohn's & colitis, 2013, Volume: 7, Issue:5

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Middle Aged; Retrospective Studies; Steroids; Treatment Outcome

2013
Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Gastroenterology, 2014, Volume: 146, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Azathioprine; Congenital Abnormalities; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Logistic Models; Mercaptopurine; Mesalamine; Middle Aged; Odds Ratio; Pregnancy; Pregnancy Complications; Retrospective Studies; Risk Factors; Severity of Illness Index; United Kingdom; Young Adult

2014
Differences in the management of pediatric and adult onset ulcerative colitis--lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis.
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:1

    Topics: Adult; Age of Onset; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Child; Colectomy; Colitis, Ulcerative; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Practice Guidelines as Topic

2014
Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Odds Ratio; Pancreatitis; Tumor Necrosis Factor-alpha; United States; United States Food and Drug Administration; Young Adult

2014
Beneficial pharmacological interaction between thiopurine and mesalazine—never change a winning team.
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:12

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Interactions; Erythrocytes; Feces; Female; Guanine Nucleotides; Humans; Immunosuppressive Agents; Leukocyte L1 Antigen Complex; Mercaptopurine; Mesalamine

2014
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.
    World journal of gastroenterology, 2015, Mar-28, Volume: 21, Issue:12

    Topics: Adolescent; Anti-Inflammatory Agents; Arylamine N-Acetyltransferase; Azathioprine; Biotransformation; Child; Chromatography, High Pressure Liquid; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Genotype; Humans; Isoenzymes; Male; Mercaptopurine; Mesalamine; Pharmacogenetics; Phenotype; Pilot Projects; Polymorphism, Genetic; Retrospective Studies; Time Factors; Treatment Outcome

2015
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.
    Cell biology and toxicology, 2015, Volume: 31, Issue:3

    Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Azathioprine; Cell Line, Tumor; Hepatocytes; Humans; Mercaptopurine; Mesalamine

2015
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
    The New Zealand medical journal, 2015, Oct-16, Volume: 128, Issue:1423

    Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha

2015
The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
    The American journal of gastroenterology, 2016, Volume: 111, Issue:9

    Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infant, Low Birth Weight; Infant, Newborn; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Prospective Studies; Recurrence; Tumor Necrosis Factor-alpha

2016
A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Azathioprine; Cardiac Imaging Techniques; Colitis, Ulcerative; Fever; Heart Failure; Humans; Hypotension; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mercaptopurine; Mesalamine; Middle Aged; Myocarditis

2016
Ulcerative Colitis.
    Digestion, 2016, Volume: 94, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Biosimilar Pharmaceuticals; Colitis, Ulcerative; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Integrins; Janus Kinases; Mercaptopurine; Mesalamine; Piperidines; Pyrimidines; Pyrroles; Remission Induction; Tumor Necrosis Factor-alpha

2016
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy.
    Journal of Crohn's & colitis, 2017, Jun-01, Volume: 11, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Demyelinating Diseases; Drug Substitution; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Infliximab; Infusions, Intravenous; Lymphoproliferative Disorders; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Mortality; Narcotics; Prednisone; Prospective Studies; Registries; Risk Factors; Sulfasalazine; Time Factors; Young Adult

2017
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
    Digestion, 2017, Volume: 96, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colectomy; Colonoscopy; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Middle Aged; Postoperative Period; Proportional Hazards Models; Recurrence; Retrospective Studies; Secondary Prevention; Treatment Outcome; Tumor Necrosis Factor-alpha

2017
Cutaneous side effects caused by treatment for inflammatory bowel disease.
    Vojnosanitetski pregled, 2016, Volume: 73, Issue:4

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporine; Drug Eruptions; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Tumor Necrosis Factor-alpha

2016
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
    Journal of gastroenterology, 2018, Volume: 53, Issue:9

    Topics: Alopecia; Antibodies, Monoclonal; Azathioprine; Biomarkers, Pharmacological; Genetic Predisposition to Disease; Genome-Wide Association Study; Genomic Structural Variation; Haplotypes; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Japan; Leukopenia; Logistic Models; Mercaptopurine; Mesalamine; Pharmacogenetics; Pyrophosphatases; Retrospective Studies; Risk; ROC Curve; Sulfasalazine

2018
Methotrexate Monotherapy for Induction and Maintenance of Clinical Remission in Ulcerative Colitis: Dead on Arrival.
    Gastroenterology, 2018, Volume: 155, Issue:4

    Topics: Colitis, Ulcerative; Humans; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction

2018
pH-Dependent 5-Aminosalicylates Releasing Preparations Do Not Affect Thiopurine Metabolism.
    Digestion, 2019, Volume: 100, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Drug Interactions; Drug Liberation; Female; Guanine Nucleotides; Humans; Hydrogen-Ion Concentration; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Mesalamine; Middle Aged; Retrospective Studies; Thionucleotides; Time Factors; Young Adult

2019
Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S-methyltransferase inhibition.
    Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Humans; Mercaptopurine; Mesalamine; Methyltransferases; Prospective Studies

2021